Statin administration and risk of cholecystectomy: a population-based case-control study

Bibliography

• Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology 1999;117(3):632-9
   PubMed Web of Science ®Google Scholar
• Jorgensen T, Kay L, Schultz-Larsen K. The epidemiology of gallstones in a 70-year-old Danish population. Scand J Gastroenterol 1990;25:335-40
   PubMed Web of Science ®Google Scholar
• Newman HF, Northup JD. The autopsy incidence of gallstones. Intern Abstr Surg 1959;109:1-13
   Google Scholar
• The MICOL Group. Prevalence of gallstone disease in 18 Italian population samples: first results from the MICOL study. In: Capocaccia L, Ricci G, Angelico F, Angelico M, Attili AF, Lalloni F; editors, Recent advances in the epidemiology and prevention of gallstone disease. Boston: Kluwer; 1991. p. 37-44
   Google Scholar
• Admirand WH, Small DM. The physicochemical basis of cholesterol gallstone formation in man. J Clin Invest 1968;47:1043
   PubMed Web of Science ®Google Scholar
• Gilloteaux J, Karkare S, Don AQ, Sexton R. Cholelithiasis induced in the Syrian hamster: evidence of intramucinous process and down regulation of 7alpha-hydroxylase (CYP7) by medroxyprogesterone. Microsc Res Tech 1997;39:56-70
   PubMed Web of Science ®Google Scholar
• Schoenfield LU, Lachin JM, the Steering Committee, and the National Gallstone Study Group. Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. Ann Intern Med 1981;95:257-82
   PubMed Web of Science ®Google Scholar
• Scragg RK, Calvert GD, Oliver JR. Plasma lipids and insulin in gallstone disease: a case control study. Br Med J 1984;289:521
   PubMed Web of Science ®Google Scholar
• Thijs C, Knipschild P. Serum lipids and gallstones: a case-control study. Gastroenterology 1990;99:843
   PubMed Web of Science ®Google Scholar
• Marks JW, Cleary PA, Albers JJ. Lack of correlation between serum lipoproteins and biliary cholesterol saturation in patients with gallstones. Dig Dis Sci 1984;29:1118
   PubMed Web of Science ®Google Scholar
• Poynter JN, Gruber SB, Higgins PD, Statins and the risk of colorectal cancer. N Engl J Med 2005;352(21):2184-92
   PubMed Web of Science ®Google Scholar
• Kaiserman N, Vinker S, Kaiserman I. Statins do not decrease the risk for wet age-related macular degeneration. Curr Eye Res 2009;34(4):304-10
   PubMed Web of Science ®Google Scholar
• Kaiserman I, Kaiserman N, Elhayany A, Vinker S. Topical beta-blockers are not associated with an increased risk of treatment for depression. Ophthalmology 2006;113(7):1077-80
   PubMed Web of Science ®Google Scholar
• Rubin DB. Inference and missing data. Biometrika 1976;63:581-92
   Web of Science ®Google Scholar
• Rubin DB. Multiple imputation for nonresponse in surveys, Wiley & Sons, New York; 1987
   Google Scholar
• Chapman BA, Wilson IR, Frampton CM, Prevalence of gallbladder disease in diabetes mellitus. Dig Dis Sci 1996;41(11):2222-8
   PubMed Web of Science ®Google Scholar
• Marks JW, Cleary PA, Albers JJ. Lack of correlation between serum lipoproteins and biliary cholesterol saturation in patients with gallstones. Dig Dis Sci 1984;29(12):1118-22
   PubMed Web of Science ®Google Scholar
• Larsen ML, Illingworth DR. Drug treatment of dyslipoproteinemia. Med Clin North Am 1994;78(1):225-45
   PubMed Web of Science ®Google Scholar
• Loria P, Bertolotti M, Cassinadri MT, Short-term effects of simvastatin on bile acid synthesis and bile lipid secretion in human subjects. Hepatology 1994;19:882-8
   PubMed Web of Science ®Google Scholar
• Mazzella G, Parini P, Festi D, Effects of simvastatin, ursodeoxycholic acid and simvastatin plus ursodeoxycholic acid on biliary lipid secretion and cholic acid kinetics in nonfamilial hypercholesterolemia. Hepatology 1992;15:1072-8
   PubMed Web of Science ®Google Scholar
• Duane WC, Hunninghake DB, Freeman ML, Simvastatin, a competitive inhibitor of HMG-CoA reductase, lowers cholesterol saturation index of gallbladder bile. Hepatology 1988;8:1147-50
   PubMed Web of Science ®Google Scholar
• Mitchell JC, Logan GM, Stone BG, Effects of lovastatin on biliary lipid secretion and bile acid metabolism in humans. J Lipid Res 1991;32:71-8
   PubMed Web of Science ®Google Scholar
• Logan G, Duane WC. Lovastatin added to ursodeoxycholic acid further reduces biliary cholesterol saturation. Gastroenterology 1990;98:15672-6
   Google Scholar
• Smit JW, van Erpecum KJ, Renooij W, The effects of the 3-hydroxy, 3-methylglutaryl coenzyme A reductase inhibitor pravastatin on bile composition and nucleation of cholesterol crystals in cholesterol gallstone disease. Hepatology 1995;21:1523-9
   PubMed Web of Science ®Google Scholar
• Smit JW, van Erpecum KJ, Portincasa P, Effects of simvastatin and cholestyramine on bile lipid composition and gallbladder motility in patients with hypercholesterolaemia. Gut 1995;37:654-6
   PubMed Web of Science ®Google Scholar
• Wilson IR, Hurrell MA, Pattinson NR, The effect of simvastatin and bezafibrate on bile composition and gall-bladder emptying in female non-insulin-dependent diabetics. J Gastroenterol Hepatol 1994;9:447-51
   PubMed Web of Science ®Google Scholar
• Reihner E, Rudling M, Stahlberg D, Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol. N Engl J Med 1990;323:224-8
   PubMed Web of Science ®Google Scholar
• Tazuma S, Kajiyama G, Yamashita G, Combination therapy with simvastatin and ursodeoxycholic acid is more effective for cholesterol gallstone dissolution than ursodeoxycholic monotherapy. J Clin Gastroenterol 1998;26:287
   PubMed Web of Science ®Google Scholar
• Akriviadis EA, Hatzigavriel M, Kapnias D, Treatment of biliary colic with diclofenac: a randomized double-blind, placebo-controlled study. Gastroenterology 1997;113:225
   PubMed Web of Science ®Google Scholar
• Goldman G, Kahn PJ, Alon R, Wiznitzer T. Biliary colic treatment and acute cholecystitis prevention by prostaglandin inhibitor. Dig Dis Sci 1989;34:809
   PubMed Web of Science ®Google Scholar
• Thornell E, Nilsson B, Jansson R, Svanvik J. Effect of short-term indomethacin treatment on the clinical course of acute obstructive cholecystitis. Eur J Surg 1991;15:127
   Google Scholar
• Thornell E, Jansson R, Svanvik J. Indomethacin intravenously: a new way for effective relief of biliary pain: a double blind study in man. Surgery 1981;90:468
   PubMed Web of Science ®Google Scholar
• Romano M, Diomede L, Sironi M, Inhibition of monocyte chemotactic protein-1 synthesis by statins. Lab Invest 2000;80:1095-100
   PubMed Web of Science ®Google Scholar
• Wang HR, Li JJ, Huang CX, Fluvastatin inhibits the expression of tumor necrosis factor-alpha and activation of nuclear factor-kappaB in human endothelial cells stimulated by C-reactive protein. Clin Chim Acta 2005;353:53-60
   PubMed Web of Science ®Google Scholar
• Bodmer M, Brauchli YB, Krähenbühl S, Statin use and risk of gallstone disease followed by cholecystectomy. JAMA 2009;302(18):2001-7
   PubMed Web of Science ®Google Scholar
• Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Statin use and the risk of cholecystectomy in women. Gastroenterology 2009;136(5):1593-600
   PubMed Web of Science ®Google Scholar